Introduction

Among the most devastating diseases, cancer annually accounts for approximately 10 million new cases worldwide. The vast majority of anticancer drugs in clinical use are limited by systemic host toxicity due to their non-specific side effects [1]. Therefore, targeted therapies, which are in contrast to the generalized cytotoxic effects of standard chemotherapy, may be a major breakthrough in the treatment of cancer.

Various carriers, which could selectively transport cytotoxic agents into cancer cells, were exploited in targeted therapies. Therefore, the elevated requirement of tumor cells for polyamines makes the polyamine pathway attractive for tumor targeted chemotherapy [2, 3]. Recent data revealed that polyamines are potential vehicles to carry diverse cytotoxic drugs [4, 5], this idea was on account of tumor cells could import both native and structurally modified polyamines from exogenous sources via the active polyamine transporter (PAT) which is up-regulated in many tumor cell lines [4, 5]. Drug–polyamine conjugates may have elevated affinity for cancer cells, and reach the targeted tissues more specifically. Indeed, diverse drugs covalently attached to polyamines have been designed following this strategy, such as F14512 has been fulfilled preclinical study [4, 6].

Systematic studies have been made to understand the structural requirements of both the drug and the polyamine motif [5]. During our search for anticancer drugs appended to excellent polyamine carriers according to the established structure-activity relationships, we found 1,8-naphthalimide architectures, which have been evaluated extensively as antitumor agents, were attractive for their marked structural similarity to anthracene, the model cargo in prior work [5, 7]. Preliminary results confirmed that the naphthalimide conjugated with both native spermidine (Spd) and synthetic homospermidine have enhanced cytotoxicity to cancer cells (e.g., Bel-7402 cells) over their normal cell counterparts (QSG7701 cells) in vitro, and induced B16 cell apoptosis [8]. These findings prompted us to design more naphthalimide–polyamine conjugates. Through continuing efforts, this pharmacore was chosen to couple with norspermidine moiety through a three-methylene ether to form a novel 3-nitro-naphthalimide norspermine conjugate (NPC-16, Fig. 1a), the synthetic route of NPC-16 was described in our previous data [8]. The current studies were designed to elucidate the nature of the response of human hepatoma HepG2 cells and Bel-7402 cells to NPC-16 in terms of growth and/or cell death.

Fig. 1
figure 1

The chemical structure, growth inhibitory effects and intracellular fluorescence intensity of NPC-16 on HepG2 cells, Bel-7402 cells and QSG7701 cells. a The chemical structure of NPC-16. b Growth inhibitory effects of NPC-16 on HepG2 cells, Bel-7402 cells, and QSG7701 cells. c The intracellular fluorescence intensity of NPC-16 on HepG2 cells, Bel-7402 cells and QSG7701 cells. d PAT recognization was detected by NPC-16 co-incubation with DFMO or Spd in HepG2 cells and Bel-7402 cells. Each point represents the means ± S.D. from four independent experiments

Full size image

Materials and methods

Materials

RNase A, rhodamine 123 (Rh123), 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT), acridine orange (AO), Z-VAD-FMK, 3-methyl adenine (3-MA), α-difluoromethyl ornithine (DFMO) and propidium iodide (PI) were purchased from Sigma (St. Louis, MO, USA). RPMI1640 and fetal calf serum (FCS) were purchased from Gibco (Grand Island, NY, USA). AnnexinV-FITC apoptosis detection kit and primary antibodies against: phospho-p70S6 kinase (p-p70S6 K, Thr389) and phospho-mTOR (p-mTOR) were all purchased from Cell Signaling Technology (Beverly, MA, USA). Primary antibodies against: Bcl-2, phospho-Bad (p-Bad, Ser136), 14-3-3, caspase 9, caspase 3, caspase 8, Beclin 1, LC3 and cytochrome c, as well as horseradish peroxidase-conjugated anti-mouse and anti-rabbit antibodies were all obtained from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Lyso-Tracker Red, Hoechst 33342, Cy5-conjugated goat anti-rabbit and goat anti-mouse secondary antibody was purchased from Biyuntian (Shanghai, China). NPC-16 was synthesized by Professor Chao-jie Wang (The Key Laboratory of Natural Medicine and Immuno-Engineering, Henan University). The stock solution of NPC-16 (10 mM) was prepared in dimethyl sulphoxide (DMSO) and diluted to various concentrations with serum-free culture medium, the final concentration of DMSO is lower than 1% and has no effect on the various parameters of the cells measured in this study. All other chemicals used in the experiments were commercial products of reagent grade.

Cell culture and treatment

HepG2 cells, Bel-7402 cells and QSG7701 cells were purchased from Shanghai Institute of Biological Science (Shanghai, China), supplemented with 1 mM glutamine and 10 or 20% (v/v) FCS respectively, and cultured at 37°C under 5% CO2 atmosphere. 1 mM aminoguanidine was added as an inhibitor of amine oxidase derived from FCS and had no effect on the various parameters of the cells measured in this study [9]. After 24 h attach, cells were treated with NPC-16 at IC50 concentration for 48 h, except cell growth assay and intracellular fluorescence intensity assay.

Cell viability assay

The growth inhibited effect of NPC-16 was evaluated in HepG2 cells, Bel-7402 cells and QSG7701 cells by the conversion of MTT to a purple formazan precipitate as previously described [9]. After cells were seeded into 96-well plates at 5,000 cells/well for 24 h, NPC-16 (0.1, 1.0, 10, 30, and 50 μM) was subsequently added and incubated for another 48 h. The inhibition rate was calculated from plotted results using untreated cells as 100% [9].

Intracellular fluorescence intensity assay

The intracellular fluorescence intensity of NPC-16 was detected by high content screening (HCS) analysis (Thermo Scientific Cellomics ArrayScan VTI, Cellomics, Pittsburgh, PA). Briefly after cells were seeded into 96-well plates at 5,000 cells/well for 24 h, the cells were stained with acridine orange (0.15 μM) for 15 min, then washed 3 times with PBS. NPC-16 (1.0, 10 or 30 μM) was added into 96-well plate and then the intracellular fluorescence intensity of NPC-16 for 30 min was detected using HCS. For PAT recognization assay, NPC-16 (30 μM) was added into 96-well plate alone or in combinated with DFMO (100 μM) and Spd (500 μM) and then the intracellular fluorescence intensity of NPC-16 for 30 min was detected using HCS. Cell numbers were determined by AO staining and intracellular fluorescence intensity of NPC-16 was detected at excitation 350 nm and emission 460 nm [9].

Cellular apoptotic evaluation

Cell apoptosis was evaluated by AnnexinV-FITC apoptosis detection kit using FACScan (Becton–Dickinson, USA). Briefly, the cells were seeded in six-well plates, and exposed to NPC-16 for 48 h, then harvested and stained according to manufacturer’s protocol. For the caspase inhibitor analysis, the cells were pretreated with 50 μM Z-VAD-FMK for 2 h. Data acquisition and analysis were controlled by CellQuest software [9].

Measurement of mitochondrial membrane potential

Mitochondrial membrane potential (MMP) was assessed by the retention of Rh123, a membrane-permeable fluorescent cationic dye. The uptake of Rh123 by mitochondria is proportional to the MMP. Briefly, cells were incubated with Rh123 (0.25 nM) in the dark at room temperature for 20 min. After being washed with PBS, the cells were analyzed by FACScan (Becton–Dickinson, USA) with excitation and emission wavelength of 495 and 535 nm, respectively [9]. Furthermore, the change of MMP was also detected using HCS. Briefly, cells, which were treated with NPC-16 for 36 h, were incubated with Rh123 (0.25 nM) in the dark at room temperature for 20 min. After being washed with PBS, cells were counterstaining with Hoechst 33342 (1 μM) for 15 min at dark. The change of MMP was analyzed by HCS [9].

Autophagy detection with acridine orange staining

As a marker of autophagy, the volume of the cellular acidic compartment was visualized by acridine orange staining [10]. Cells were seeded into 6-well plates and treated as described above for the cell viability study. After 48 h treatment, cells were incubated with medium containing acridine orange (0.15 μM) for 15 min. For the autophagy inhibitor analysis, the cells were pretreated with 3-MA (5 mM) for 2 h. Acridine orange was removed and fluorescent micrographs were taken using HCS.

Lysosomes detection with Lyso-Tracker Red staining

After NPC-16 incubation, cells were stained with Lyso-Tracker Red (50 nM), a specific red fluorescent dye for lysosomes, for 45 min at 37°C and then counterstaining with Hoechst 33342 (1 μM) for 15 min at dark. The fluorescent micrographs were taken using HCS [11].

Immunofluorescence assay

After NPC-16 incubation, cells were fixed in methanol for 5 min at −20°C, rinsed with PBS, permeabilizied in 0.1% Triton X-100, blocked in PBS containing 5% BSA (1 h at 25°C), and labeled with primary antibody (overnight at 4°C) anti-active Beclin 1 and LC3 II. Cy5-conjugated secondary antibody was incubated for 1 h at 25°C. Nuclear counterstaining was performed using Hoechst 33342 (1 μM) for 15 min at dark [12]. Fluorescence was quantitated using HCS.

Western blots

After treatment, HepG2 cells and Bel-7402 cells were harvested and washed with PBS. Cytosolic and mitochondrial fractions were prepared as previously described [9]. Total cellular protein was isolated using the protein extraction buffer (containing 150 mM NaCl, 10 mM Tris (pH 7.2), 5 mM EDTA, 0.1% Triton X-100, 5% glycerol, and 2% SDS). Protein concentration was determined using the protein assay kit (Biyuntian, China). Equal amounts of proteins (50 μg/lane) were fractionated using 8 or 12% SDS–PAGE and transferred to PVDF membranes. The membranes were incubated with primary antibodies. After washing with PBS, the membranes were incubated with corresponding peroxidase-conjugated goat anti-mouse or anti-rabbit secondary antibody, followed by enhanced chemiluminescence staining through the enhanced chemiluminescence system. β-Actin (45 kDa, cytosolic protein) and voltage-dependent anion-selective channel protein (31 kDa, mitochondrial protein) were used to normalize for protein loading [9].

Data analysis

All data are presented as mean ± SD and analyzed using students t test or analysis of variance (ANOVA) followed by q test.

Results

NPC-16 exerted potent antiproliferative activity and tumor selectivity

Three cell lines (hepatoma HepG2 cell line, Bel-7402 cell line and normal hepatocyte QSG7701 cell line) were selected to assess the antiproliferative activity and tumor selectivity of NPC-16. The IC50 value is 89.6 ± 5.1, 5.9 ± 0.3 and 9.1 ± 0.6 μM for QSG7701 cells, HepG2 cells and Bel-7402 cells, respectively. As shown in Fig. 1b, the proliferation of HepG2 cells and Bel-7402 cells which were treated with NPC-16 for 48 h was significantly decreased in a dose-dependent manner. However, the antiproliferative effect of NPC-16 is markedly lower on QSG7701 cells than HepG2 cells or Bel-7402 cells, suggesting that NPC-16 has tumor cell selectivity.

Intracellular NPC-16 uptake

We detected the intracellular fluorescence intensity of NPC-16 using HCS, demonstrating NPC-16 could be uptake into cells. As shown in Fig. 1c, the intracellular fluorescence intensity of NPC-16 was obvious higher in HepG2 cells and Bel-7402 cell than in QSG7701 cells, supporting NPC-16 has tumor cells selectivity. Furthermore, DFMO enhances and Spd attenuates this fluorescence intensity, respectively, which supported that NPC-16 was intake via PAT (Fig. 1d). DFMO, an irreversible inhibitor of ornithine decarboxylase, inhibits cellular polyamine biosynthesis by generally facilitates the import of exogenous polyamines or polyamine-drug conjugates via PAT. In addition, Spd rescue experiments were conducted to test whether these conjugates were using the PAT for cellular entry. Because Spd is a natural PAT substrate, it should outcompete the PAT-selective conjugates for cellular entry [9].

NPC-16 induced cell apoptosis

Next, we investigated whether NPC-16-induced cell death was caused by apoptosis. AnnexinV/PI double-labeling was used for the detection of PS externalization, a hallmark of early phase apoptosis. Compared with control cells, the percentage of annexin V-positive cells increased after treatment with NPC-16 at concentrations corresponding to IC50 value (Fig. 2a). Furthermore, apoptotic effects were almost completely attenuated in Bel-7402 cells and partly degraded in HepG2 cells after pre-treated with Z-VAD-FMK, an extensive caspase inhibitor. NPC-16 induced caspase 8, caspase 9 and caspase 3 activation, suggesting the caspase family of proteins were involved in NPC-16-mediated cell apoptosis.

Fig. 2
figure 2

NPC-16 induced cell apoptosis in HepG2 cells and Bel-7402 cells. a Apoptosis was evaluated by AnnexinV-FITC apoptosis detection kit. b The protein expression of caspase 8, caspase 9 and caspase 3 was detected by Western blot

Full size image

NPC-16 induced cell autophagy

Autophagy is also one of reasons for cell growth inhibition [10], so the possibility of autophagic vacuole formation associated with autophagic cell death was evaluated. Figure 3a indicates that there was significant autophagic vesicle (red fluorescence) formation in HepG2 cells exposed to NPC-16, based on acridine orange staining. In the process of autophagic vesicle formation, the numbers and activity of lysosomes is increase, so we further detected lysosomes using Lyso-Tracker Red, a specific red fluorescent dye for lysosomes. As shown in Fig. 3b, the fluorescence of Lyso-Tracker Red was obvious increase after treatment with NPC-16, indicating that NPC-16 induced HepG2 cells Autophagy. Furthermore, immunofluorescence assay demonstrated that up-regulation of Beclin 1 (initiation factor for autophagosome formation), and conversion of LC3 I to LC3 II (autophagosome marker) after NPC-16 treatment (Fig. 3c). These results indicated that NPC-16 induced HepG2 cells autophagy. Next, we evaluated NPC-16-mediated autophagy whether promoted or inhibited cell apoptosis in HepG2 cells. As shown in Fig 3d, the apoptotic cell population significantly increased after NPC-16 treatment compared to control. In contrast, inhibition of autophagy by 3-MA significantly decreased cell apoptosis, suggesting this autophagy plays a facilitative role in NPC-16-induced cell apoptosis. Furthermore, p70S7 K and mTOR were also involved in NPC-16-mediated autophagy, the phosphorylation protein expression of p70S7 K and mTOR was up-regulation after NPC-16 treatment and 3-MA could inhibit this effect. In contrast, NPC-16 had no obvious effect on basal p70S7 K (Fig. 3e). However, the effects of autophagy above was not detected in Bel-7402 cells after treatment with NPC-16 (data not shown), suggesting NPC-16 only induced HepG2 cells autophagy, but not Bel-7402 cells.

Fig. 3
figure 3

NPC-16 triggered autophagy in HepG2 cells. a Autophagy was detected using acridine orange staining. b Lysosomes were detected using Lyso-Tracker Red and Hoechst 33342 staining. c Beclin 1 and LC3 II were detected using immunofluorescence assay. d Apoptosis was evaluated by AnnexinV-FITC apoptosis detection kit. e The protein expression of p-mTOR, p-p70S6 K and p70S6 K was detected by Western bolt. Representative pictures are from one of three independent experiments with similar results (magnification, ×20). Compared with control * P < 0.05, ** P < 0.01

Full size image

NPC-16 induced cell apoptosis was involved in mitochondria and Bcl-2 family members

To explore whether NPC-16-induced cell apoptosis was correlated with mitochondrial dysfunction, we examined the MMP change by mitochondria sensitive dye, Rh123, using flow cytometry. As shown in Fig. 4a, e, the MMP of HepG2 cells and Bel-7402 cells decreased significantly after treatment with NPC-16 in a time-dependent manner, NPC-16-induced MMP loss also was authenticated by Rh123 and Hoechst 33342 staining (green fluorescence decrease) (Fig. 4b, f), and accordingly facilitated cytochrome c release from mitochondria to cytoplasm, respectively (Fig. 4c, g). Bcl-2 family proteins were often involved in mitochondria-mediated apoptosis. Thus, we examined whether the Bcl-2 family protein levels were altered after NPC-16 exposure. Result of Western blot analysis revealed that NPC-16 significantly induced Bad Ser136 dephosphorylation and decreased the expression of 14-3-3 and Bcl-2, although the down-regulation of Bcl-2 protein expression is not significant (Fig. 4d, h). These results suggested that mitochondria and Bcl-2 family members were involved in NPC-16-mediated cell apoptosis in HepG2 cells and Bel-7402 cells.

Fig. 4
figure 4

The change of MMP and Cyto C, 14-3-3, p-Bad and Bcl-2 were detected using Rh123 staining and Western blot in HepG2 cells and Bel-7402 cells, respectively. a, e The change of MMP was detected by Rh123 staining using flow cytometry. b, f The change of MMP was detected by Rh123 and Hoechst 33342 double staining using HCS. Representative pictures are from one of three independent experiments with similar results (magnification, ×20). c, d, g, h The protein expression of Cyto C, 14-3-3, p-Bad and Bcl-2 was detected by Western blot

Full size image

Discussion

Recent reviews demonstrated that polyamines were an ideal vector for targeted drug delivery for tumor cell [13]. Although previous study demonstrated that naphthalimide–polyamine conjugates could distinguish tumor cells from normal ones [8], the relationship between this cell selectivity and polyamine transporter (PAT) recognition is still unknown. Our data demonstrated that the antiproliferative effect of NPC-16 was obviously different between human hepatoma HepG2 cells, Bel-7402 cells and normal hepatocyte QSG7701 cells. This antiproliferative effect was parallel with intracellular concentration, for the intracellular fluorescence intensity of NPC-16 was significant higher in HepG2 cells and Bel-7402 cells than QSG7701 cells.

Many data demonstrated that polyamine derivatives or naphthalimides derivatives could induce tumor cells apoptosis [14, 15], however, the reports about naphthalimide–polyamine conjugate induced tumor cell apoptosis are rare. Our results revealed that NPC-16 induced Bel-7402 cells apoptosis via caspase-dependent pathway, this result was similar with ANTMHspd, an anthracenylmethyl-homospermidine conjugate [16]. Nevertheless, pre-incubated with Z-VAD-FMK, an extensive caspase inhibitor, only partly inhibited NPC-16-induced cell apoptosis in HepG2 cells. This was different with ANTMHspd which was induced Bel-7402 cells caspase-dependent apoptosis only via mitochondrial pathway, while NPC-16 induced HepG2 cells apoptosis via both mitochondrial pathway and death receptor pathway [16], suggesting that the mother nuclide of polyamine conjugates determined the molecular apoptotic mechanism and polyamine, in spite of natural polyamines or synthetical polyamines, only a tumor targeted vector. Our previous data demonstrated that naphthalimide–polyamine conjugates inhibited mTOR signal pathway [17], and mTOR was often involved in cell autophagy [18]. So we further detected whether NPC-16 induced cell autophagy. After NPC-16 treatment, the autophagic vesicle formation and the activity of lysosome were increase in HepG2 cells. Furthermore, up-regulation of Beclin 1 and conversion of LC3 I to LC3 II, which are initiation factor for autophagosome formation and autophagosome marker respectively, were also acquired in HepG2 cells after exposure to NPC-16. Likewise, NPC-16 inhibited the phosphorylation of p70S6 K and mTOR as some naphthalimide–polyamine conjugates [17], suggesting NPC-16 mediated-autophagy was involved in mTOR signal pathway in HepG2 cells. However, NPC-16 did not affect the mTOR signal and induce autophagy in Bel-7402 cells, suggesting mTOR signal maybe a vital role in NPC-16-mediated cell autophagy. It was previously suggested that autophagy and apoptosis were co-existed, and autophagy had a dual role, facilitation or inhibition apoptosis, in drugs-induced apoptosis [19]. For instance, arsenic trioxide induced not only apoptosis but also autophagy in leukemia cell lines through up-regulation of Beclin 1 [20]. After pre-incubated with 3-MA, the apoptotic cells populations of NPC-16 treatment was obvious decrease, suggesting NPC-16-mediated autophagy facilitated cell apoptosis. This effect was different with oridonin which exerted a protective mechanism against apoptosis [21].

Mitochondria and Bcl-2 family proteins are key factors in apoptotic signal pathway. Mitochondrial dysfunction often involves MMP loss and cytochrome c release from mitochondria into cytosol [22, 23]. We found that the NPC-16-induced loss of MMP was accompanied with the release of cytochrome c from mitochondria into cytoplasm, suggesting that the NPC-16 induced cell apoptosis was correlated with mitochondrial dysfunction. This effect is similar to that of ANTMHspd [16] but not that of DENspm [24], for DENspm only triggered the release of cytochrome c from mitochondria without decreasing the MMP of mitochondria. Previous studies have shown that Bcl-2 family proteins were usually involved in polyamine conjugate induced mitochondria apoptotic signal pathway [25, 26]. Accordingly, we turned our attention to Bad and Bcl-2, two pivotal pro-apoptotic and anti-apoptotic Bcl-2 family members [27]. Our results demonstrated that NPC-16 induced Bcl-2 down-regulation and Bad dephosphorylation, and then dissociation of Bad from 14-3-3. These supported that mitochondria and Bcl-2 family proteins are involved in NPC-16-induced cells apoptosis.

In summary, the novel NPC-16 vectored into tumor cells via the polyamine transporter could discriminate tumor cells from normal ones. Our study suggested that NPC-16-mediated apoptosis were due to mitochondrial pathway and death receptor pathway and Bcl-2 family members were also involved in this apoptotic process in HepG2 cells and Bel-7402 cells. Furthermore, NPC-16 induced concomitance of apoptosis and autophagy, and autophagy facilitated cell apoptosis in HepG2 cells. Thus, NPC-16 may be useful as a potential template for investigation the molecular mechanism of naphthalimide–polyamine conjugate against hepatocellular carcinoma.